These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1184 related articles for article (PubMed ID: 22098312)

  • 1. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
    Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
    J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.
    Xue F; Chen W; Wang X; Wang L; Xu G; Liang L; Bai X; Liang T
    Transpl Immunol; 2009 Mar; 20(4):232-7. PubMed ID: 19041396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
    Encabo A; Solves P; Carbonell-Uberos F; Miñana MD
    Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G; He J; Zhang Z; Leventhal JR
    Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of CD4+CD25+ regulatory T cells for prevention and treatment of spontaneous abortion.
    Yin Y; Han X; Shi Q; Zhao Y; He Y
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):177-81. PubMed ID: 22261465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
    Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis and gene expression profile of umbilical cord blood regulatory T cells.
    Torelli GF; Maggio R; Peragine N; Chiaretti S; De Propris MS; Lucarelli B; Screnci M; Mascolo MG; Milano F; Iori AP; Girelli G; Guarini A; Foà R
    Ann Hematol; 2012 Feb; 91(2):155-61. PubMed ID: 21732086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid attenuates acute heart rejection by increasing regulatory T cell and repressing differentiation of Th17 cell in the presence of TGF-β.
    Wang G; Zhong A; Wang S; Dong N; Sun Z; Xia J
    Transpl Int; 2010 Oct; 23(10):986-97. PubMed ID: 20412539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infusion of ex vivo expanded homologous CD4⁺;CD25⁺; regulatory T cells promotes the susceptibility to tumor in mice].
    Guo T; Luo S; Xu J; Dai J; Liu Z; Gao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):466-70. PubMed ID: 24796739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation.
    Yang J; Li R; Ren Y; Yang Y; Xie R; Fan H
    Scand J Immunol; 2013 Dec; 78(6):486-96. PubMed ID: 24283771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
    Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
    Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.